Literature DB >> 1311925

PAF-induced activation of polyphosphoinositide-hydrolyzing phospholipase C in cerebral cortex.

R E Catalán1, A M Martínez, M D Aragonés, I Fernández, M Lombardía, B G Miguel.   

Abstract

The action of platelet-activating factor (PAF) on phosphoinositide hydrolysis was studied in rat brain slices. PAF produced a significant increase of 32P incorporation into phosphoinositides and phosphatidic acid (PA), in a dose- and time-dependent manner. Concomitantly, an increase of inositol phosphates and diacylglycerol (DAG) production was observed. Both inositol bisphosphate (IP2) and inositol trisphosphate (IP3) were detected as early as 5 s and they returned immediately to basal levels; concomitantly, formation of inositol monophosphate (IP) was detected. These findings demonstrated that PAF causes a rapid hydrolysis of polyphosphoinositides in cerebral cortex by a phospholipase C-dependent mechanism followed by subsequent resynthesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311925     DOI: 10.1016/0006-291x(92)91643-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Further studies on the mechanism of action of substance P in rat brain, involving selective phosphatidylinositol hydrolysis.

Authors:  R E Catalán; A M Martínez; M D Aragonés; F Hernández; A Liras; B G Miguel
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

2.  Lissencephaly gene product. Localization in the central nervous system and loss of immunoreactivity in Miller-Dieker syndrome.

Authors:  M Mizuguchi; S Takashima; A Kakita; M Yamada; K Ikeda
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

Review 3.  Enzymes of platelet activating factor synthesis in brain.

Authors:  R R Baker
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

Review 4.  Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease.

Authors:  Hang Yin; Anhua Shi; Junzi Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-08       Impact factor: 3.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.